Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities... Show more
CME Group operates as the world’s leading derivatives marketplace, offering futures and options across interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. Its core strength lies in the concentration of liquidity in benchmark contracts, which creates powerful network effects that attract participants and reinforce market dominance.
Competitive advantages include proprietary market data, a robust clearing infrastructure that mitigates counterparty risk, and the Globex electronic trading platform. A strategic partnership with Google supports technology investments aimed at advancing artificial intelligence capabilities. These elements collectively support medium-term positioning by expanding revenue streams beyond execution fees into market data, connectivity, and benchmark services.
Several developments could shape sentiment in the periods ahead. Regular quarterly earnings releases provide updates on trading volumes, revenue from clearing and data services, and guidance on operational priorities. Product innovations, such as expansions in micro futures or new offerings in emerging asset classes, may attract additional participants and boost activity levels.
Regulatory decisions regarding central clearing requirements or cryptocurrency-related products could expand addressable markets. Capital allocation decisions, including share repurchases or investments in technology infrastructure, often influence perceptions of financial flexibility. Shifts in analyst ratings or price target revisions from major firms can also affect visibility, with consensus views typically highlighting the resilience of CME Group’s ecosystem amid broader market changes.
CME Group’s business model is closely tied to hedging needs driven by macroeconomic conditions. Interest rate volatility directly influences activity in Treasury and interest rate futures, while equity market fluctuations support equity index products. Commodity price movements and geopolitical developments tend to increase demand for energy and agricultural derivatives as participants seek to manage exposure.
Broader trends such as inflation dynamics, shifts in global trade, and technology adoption in financial markets further connect to the company’s role in price discovery and risk transfer. Regulatory climate changes affecting derivatives trading or clearing standards may also impact operational requirements and growth opportunities.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. Trend Prediction Engine
Looking toward 2026 and beyond, CME Group is expected to focus on expanding its ecosystem through technology transitions, particularly the integration of artificial intelligence to enhance trading and data capabilities. Market expansion opportunities may arise from increased global participation in derivatives and growth in areas such as environmental products or digital assets.
Cost structure evolution and margin sustainability will depend on maintaining high trading volumes and diversifying revenue from clearing and information services. Competitive threats from fintech platforms or alternative venues could influence market share, while regulatory developments may shape clearing standards and product approvals. Capital allocation priorities, including technology investments and shareholder returns, remain central to long-term positioning. Consensus analyst expectations often emphasize the company’s structural advantages in liquidity and risk management infrastructure as foundational to sustained performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
an operator of securities and commodity exchanges
Industry FinancialPublishingServices
A.I.dvisor indicates that over the last year, CME has been loosely correlated with TW. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CME jumps, then TW could also see price increases.
| Ticker / NAME | Correlation To CME | 1D Price Change % | ||
|---|---|---|---|---|
| CME | 100% | +5.00% | ||
| TW - CME | 45% Loosely correlated | +1.60% | ||
| ICE - CME | 45% Loosely correlated | +2.78% | ||
| MKTX - CME | 35% Loosely correlated | +0.61% | ||
| NDAQ - CME | 32% Poorly correlated | +0.73% | ||
| SNEX - CME | 23% Poorly correlated | -0.71% | ||
More | ||||
| Ticker / NAME | Correlation To CME | 1D Price Change % |
|---|---|---|
| CME | 100% | +5.00% |
| Financial Publishing/Services industry (15 stocks) | 8% Poorly correlated | +0.24% |
| Commercial Services industry (95 stocks) | 6% Poorly correlated | +0.09% |
The RSI Indicator for CME moved out of oversold territory on July 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In of the 14 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on July 22, 2026. You may want to consider a long position or call options on CME as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CME just turned positive on July 06, 2026. Looking at past instances where CME's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in of 340 cases, the price rose further within the following month. The odds of a continued upward trend are .
CME may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 68 cases where CME's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The 50-day moving average for CME moved below the 200-day moving average on June 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CME entered a downward trend on July 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.383) is normal, around the industry mean (5.381). P/E Ratio (21.266) is within average values for comparable stocks, (25.074). CME's Projected Growth (PEG Ratio) (4.375) is very high in comparison to the industry average of (2.065). CME has a moderately high Dividend Yield (0.045) as compared to the industry average of (0.019). P/S Ratio (13.316) is also within normal values, averaging (8.112).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CME’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.